Experts Statements: Shawn Conway, Cambrex High Point
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
Topics
Flow Chemistry - A Mature Technology still on the Rise
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
20.04.2020 • Topics • Innovation
Smart Tools for Chemical Research
Iris.ai was founded at Singularity University at NASA Ames Research Park in 2015. Challenged to come up with an idea that would positively impact the lives of 1 billion people, the team was formed and problem areas were explored.
20.04.2020 • Topics • Technology
Analytics Software for Chemical Plants
Nanoforming
In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.
Agrochemical and Custom Manufacturing Industry: Connected Fates
The fate of the agrochemical innovation, development, product launch and production are strongly linked to the parallel development of the fine chemicals and custom manufacturing industry.
Flow Chemistry: A Mature Technology still on the Rise
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
16.04.2020 • Topics • Technology
Flow Chemistry Opens up New Possibilities
24.03.2020 • Topics • Innovation
Expert Webinar: Accelerating Drug Commercialization
New therapies to address unmet and emerging medical needs are being discovered at an explosive rate, building on rapid advances in molecular biology and genetics.
Changing Customer Needs in the Supply Chain
As customers engage in more multi-channel interactions, having a deep understanding of these journeys is an essential component for the customer service function, and for ensuring excellence in the overall customer experience.
Outsourcing Services: from Gene to Patient
Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient processes, Rentschler Biopharma is the preferred outsourcing partner for bioprocess development, cGMP manufacturing, as well as elaboration of product approval strategies for over 150 clients worldwide.
